A shipment of over 1.4 million doses of the bivalent human papillomavirus (HPV) vaccine "Cecolin" recently arrived at Luanda International Airport in Angola. These vaccines, produced in Xiamen, will support Angola's nationwide immunization program for girls aged 9 to 12. This marks a successful collaboration between Xiamen Innovax Biotech Co., Ltd. and UN agencies. As the first domestically developed cervical cancer vaccine, "Cecolin" received WHO Prequalification (PQ) certification in 2021, qualifying it for large-scale public procurement by UN agencies. Since its first export to Thailand in March 2023, "Cecolin" has gained market access in 20 countries and has been included in HPV immunization programs in four nations.
